false
Catalog
The Lead Episode 18: A Discussion of Substrate Map ...
The Lead Episode 18 Speaker Information
The Lead Episode 18 Speaker Information
Back to course
Pdf Summary
This document is a discussion on substrate mapping and its impact on the inducibility of ventricular tachycardia. The article is authored by Asad A. Aboud, MD, Giovanni Davogustto, MD, Oluwaseun Adeola, MD, Travis D. Richardson, MD, Kenichi Tokutake, MD, Gregory F. Michaud, MD, William G. Stevenson, MD, and Arvindh Kanagasundram, MD.<br /><br />The discussion is led by Jason T. Jacobson, MD, FHRS from the Westchester Medical Center-New York Medical College. The contributors for this discussion include Usha B. Tedrow, MD, MS, FHRS from Brigham and Women’s Hospital and David S. Frankel, MD, FHRS from the Hospital of the University of Pennsylvania.<br /><br />The document also includes disclosures from the contributors. David S. Frankel, MD, FHRS, and Jason T. Jacobson, MD, FHRS have received honoraria, speaking fees, and consulting fees from organizations such as the American College of Cardiology, Zoll Medical Corporation, and Atlas 5D. They have also conducted research for Aboot and Phillips and have stock in Atlas 5D. Usha B. Tedrow, MD, MS, FHRS has received honoraria, speaking fees, and consulting fees from organizations such as Biosense Webster, Inc., St. Jude Medical, Thermedical, Medtronic, Boston Scientific, and Baylis Medical Company.<br /><br />This document provides an overview of the topic of substrate mapping and how it affects the inducibility of ventricular tachycardia. It is a discussion among experts in the field and includes disclosures of potential conflicts of interest.
Keywords
substrate mapping
ventricular tachycardia
inducibility
disclosures
honoraria
speaking fees
consulting fees
research
stock
conflicts of interest
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English